Who owns BICARA THERAPEUTICS INC?
- Ticker: BCAX
- CUSIP Number: 055477103
Tip: Access positions for across all investors
Analyze quarterly positions in Bicara Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bicara Therapeutics stock
Who bought or sold BICARA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 7.0M | $177M | 100% | Sep 2024 |
|
| Siren | 3.1M | $78M | 100% | Sep 2024 |
|
| Tpg Gp A | 3.0M | $77M | 100% | Sep 2024 |
|
| FMR | 2.3M | $58M | 100% | Sep 2024 |
|
| Omega Fund Management | 2.2M | $56M | 100% | Sep 2024 |
|
| Deerfield Management Company | 1.8M | $46M | 100% | Sep 2024 |
|
| Braidwell | 1.7M | $42M | 100% | Sep 2024 |
|
| T. Rowe Price Associates | 1.5M | $39M | 100% | Sep 2024 |
|
| Fairmount Funds Management | 1.3M | $33M | 100% | Sep 2024 |
|
| Henderson Group | 1.2M | $30M | 100% | Sep 2024 |
|
| Fil | 1.0M | $26M | 100% | Sep 2024 |
|
| Baker Bros. Advisors | 833k | $21M | 100% | Sep 2024 |
|
| Logos Global Management | 800k | $20M | 100% | Sep 2024 |
|
| Adage Capital Partners GP | 800k | $20M | 100% | Sep 2024 |
|
| Deep Track Capital | 797k | $20M | 100% | Sep 2024 |
|
| Wellington Management Company | 764k | $20M | 100% | Sep 2024 |
|
| Alliancebernstein | 708k | $18M | 100% | Sep 2024 |
|
| Blackstone Group | 650k | $17M | 100% | Sep 2024 |
|
| Aisling Capital Management | 569k | $15M | 100% | Sep 2024 |
|
| First Turn Management | 562k | $14M | 100% | Sep 2024 |
|
| Rock Springs Capital Management | 446k | $11M | 100% | Sep 2024 |
|
| Vestal Point Capital | 425k | $11M | 100% | Sep 2024 |
|
| Point72 Asset Management | 372k | $9.5M | 100% | Sep 2024 |
|
| Millennium Management | 300k | $7.6M | 100% | Sep 2024 |
|
| Woodline Partners | 278k | $7.1M | 100% | Sep 2024 |
|
| OrbiMed Advisors | 272k | $6.9M | 100% | Sep 2024 |
|
| Citadel Advisors | 234k | $6.0M | 100% | Sep 2024 |
|
| Ameriprise Financial | 200k | $5.1M | 100% | Sep 2024 |
|
| Iron Triangle Partners | 200k | $5.1M | 100% | Sep 2024 |
|
| Boxer Capital | 135k | $3.4M | 100% | Sep 2024 |
|
| Nicholas Investments Partners | 118k | $3.0M | 100% | Sep 2024 |
|
| TD Asset Management | 102k | $2.6M | 100% | Sep 2024 |
|
| Goldman Sachs Group | 102k | $2.6M | 100% | Sep 2024 |
|
| Alyeska Investment Group | 73k | $1.9M | 100% | Sep 2024 |
|
| Vanguard Group | 70k | $1.8M | 100% | Sep 2024 |
|
| Point72 | 56k | $1.4M | 100% | Sep 2024 |
|
| Maven Securities | 50k | $1.3M | 100% | Sep 2024 |
|
| Geode Capital Management | 49k | $1.2M | 100% | Sep 2024 |
|
| Squarepoint Ops | 45k | $1.1M | 100% | Sep 2024 |
|
| ADAR1 Capital Management | 40k | $1.0M | 100% | Sep 2024 |
|
| Samsara BioCapital | 35k | $892k | 100% | Sep 2024 |
|
| Walleye Trading Advisors | 32k | $809k | 100% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 23k | $582k | 100% | Sep 2024 |
|
| Soros Fund Management | 20k | $509k | 100% | Sep 2024 |
|
| Rhumbline Advisers | 19k | $331k | 100% | Dec 2024 |
|
| Point72 Asia | 18k | $462k | 100% | Sep 2024 |
|
| Scientech Research | 18k | $458k | 100% | Sep 2024 |
|
| New York State Common Retirement Fund | 17k | $439k | 100% | Sep 2024 |
|
| Teachers Retirement System Of The State Of Kentucky | 14k | $358k | 100% | Sep 2024 |
|
| Greenland Capital Management | 12k | $313k | 100% | Sep 2024 |
|
| Jane Street | 12k | $310k | 100% | Sep 2024 |
|
| Caxton | 11k | $279k | 100% | Sep 2024 |
|
| Barclays | 10k | $255k | 100% | Sep 2024 |
|
| Ghisallo Capital Management | 10k | $255k | 100% | Sep 2024 |
|
| Davidson Kempner Capital Management | 10k | $255k | 100% | Sep 2024 |
|
| Cinctive Capital Management | 9.0k | $229k | 100% | Sep 2024 |
|
| Two Sigma Investments | 9.0k | $229k | 100% | Sep 2024 |
|
| Bank of America Corporation | 8.9k | $227k | 100% | Sep 2024 |
|
| SG Americas Securities | 8.4k | $147k | 100% | Dec 2024 |
|
| Federated Investors | 8.0k | $204k | 100% | Sep 2024 |
|
| UBS Group | 2.8k | $71k | 100% | Sep 2024 |
|
| Spire Wealth Management | 1.8k | $31k | 100% | Dec 2024 |
|
| Jpmorgan Chase & Co | 730.00 | $19k | 100% | Sep 2024 |
|
| Citigroup | 252.00 | $6.4k | 100% | Sep 2024 |
|
| 13F Holdings Report | 200.00 | $3.5k | 0% | Dec 2024 |
|
| Royal Bank of Canada | 100.00 | $3.0k | 100% | Sep 2024 |
|
| GAMMA Investing | 59.00 | $1.0k | 100% | Dec 2024 |
|
| Advisor Group Holdings | 37.00 | $942.001500 | 100% | Sep 2024 |
|
| MRP Capital Investments | 20.00 | $510.000000 | 100% | Sep 2024 |
|
Who sold out of Bicara Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Legato Capital Management | Sep 2024 | 14k | $361k |